CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Authors
Gursel Aktan
Claudia Aura
+20 more
José Baselga
Ian Bradbury
Tsai-Wang Chang
Maria Coccia-Portugal
Evandro de Azambuja
Serena Di Cosimo
Phuong Dinh
Julien Domont
Holger Eidtmann
Karine Fauria
Aron Goldhirsch
Henry Gómez
Zsolt Horváth
Georg Kunz
Guillermo Lerzo
Marketa Palacova
Vladimir Semiglazov
Joo Hyuk Sohn
Ling-Min Tseng
Veerle Van Dooren
Publication date
1 December 2017
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
University of Debrecen Electronic Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dea.lib.unideb.hu:2437/233...
Last time updated on 12/09/2018